Patent ID: 7977315

Claim:
A method for the treatment of cancer in a patient, the method comprising administering an effective amount of a compound of Formula (I) or pharmaceutically acceptable salt thereof, wherein: G 1 is selected from the group consisting of alkyl, haloalkyl, alkoxy, alkylthio and the sulfoxide and sulfone derivatives thereof, alkenyl, cycloalkyl, cycloalkoxy, aryl, aralkyl, aryloxy, heterocyclo, optionally substituted heterocyclo, alkynyl, alkanoyl, aroyl, aminocarbonyl, aminoalkanoyl, optionally substituted aminoalkanoyl, alkoxycarbonyl, alkylcarbonyloxy, alkoxyalkanoyl, alkanoylamido, a polypeptide, and combinations thereof; G 2 and G 3 are independently a hydrogen atom or a substituent selected from the group consisting of alkyl, haloalkyl, alkoxy, alkylthio and the sulfoxide and sulfone derivatives thereof, alkenyl, cycloalkyl, cycloalkoxy, aryl, aralkyl, aryloxy, heterocyclo, optionally substituted heterocyclo, alkoxyalkyl, alkynyl, alkanoyl, aroyl, aminocarbonyl, aminoalkanoyl, optionally substituted aminoalkanoyl, carbocycloalkyl, optionally substituted carbocycloalkyl, heteroaryl, optionally substituted heteroaryl, halo, (heterocyclo)alkyl, (heteroaryl)alkyl, alkoxycarbonyl, alkylcarbonyloxy, alkoxyalkanoyl, alkanoylamido, a polypeptide, and combinations thereof; or G 1 , G 2 , or G 3 is a peptidomimetic group selected from the group consisting of and L is selected from the group consisting of a bond, alkyl, alkenyl, alkynyl, and aralkyl, with the provisos that (i) when L is a bond, G 1 is not aryl and (ii) G 2 and G 3 are not both hydrogen.